MUGEX ← Got Dropped into a Ghost Story, Still Gotta Work
Locked1 coin
This device0%
Chapter

148

Baekilmong Co., Ltd.

A pharmaceutical company that manufactured fantastical potions capable of granting wishes in a way no one could understand.

Its raw material was Ghost Stories.

……That much was what Darkness Exploration Record had recorded when this corporation first appeared.

Because there was no explanation, it only made people imagine more, and its bizarre technical power, mystery, cruelty, and blank spaces all came across as even more chilling.

But the more the wiki accumulated, the more hooks accumulated with it.

‘Background lore gets attached to it.’

Naturally, Baekilmong Co., Ltd. could not simply drop out of the sky out of nowhere complete with perfect, unknown pharmaceutical technology.

Even if that was how it looked, once you dug into it, you had to be able to infer its origin and history…. Because that was what made it thrilling and fun.

And in the end, as time passed, Darkness Exploration Record gradually received meaningful exploration records here and there, and readers became able to construct and speculate about several conspiracy theories regarding Baekilmong.

—What exactly is Baekilmong Co., Ltd.?

And the place I was visiting right now… was evidence for Conspiracy Theory No. 2.

Conspiracy Theory No. 2: Baekilmong Co., Ltd. was not originally a pharmaceutical company.

Specifically, Baekilmong Co., Ltd.’s pharmaceutical technology, and its original source.

“…Whew.”

Swallowing hard, I began to look around the “Dream Incubation Chamber.”

The dust-covered laboratory looked like the science room of an abandoned school, or an old lab left behind after the end of the world.

Everything looked dead.

Workbenches and laboratory equipment, beakers and display shelves filled with unidentified liquids.

And… the enormous machine in the center.

“……”

10% preview

Continue reading Chapter 148

Sign in to use your MUGEX coins and unlock the rest of this chapter.

Chapter cost1 coin
Your balance
AccessSign in required